ATOSSA THERAPEUTICS, INC. (ATOS)
About ATOSSA THERAPEUTICS, INC.
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2015
- $1.8K
- Net income
- -$34.8M
- Total assets
- $47.6M
- Market cap
- $38.5M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $37.1M
- Operating income
- -$37.1M
- Income tax
- $0
- Net income
- -$34.8M
- EPS (basic)
- $-4.04
- EPS (diluted)
- $-4.04
Balance sheet
- Total assets
- $47.6M
- Current assets
- $45.6M
- Total liabilities
- $8.3M
- Current liabilities
- $8.3M
- Shareholders’ equity
- $39.4M
Cash flow
- Operating cash flow
- -$29.8M
- Investing cash flow
- -$23.0K
- Financing cash flow
- $29.8M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $38.5M
- EPS (diluted)
- $-4.04
- Shares outstanding
- 16.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 8, 2012
Atossa Therapeutics, Inc. (ATOS) Stock Price
- Reported a net loss of $34.8M in FY2015.
- Trading 87% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ATOSSA THERAPEUTICS, INC..
Write a review
News about ATOSSA THERAPEUTICS, INC.
News & sentiment via Polygon.io
Atossa Therapeutics, Inc.: frequently asked questions
Is Atossa Therapeutics, Inc. an American company?
Atossa Therapeutics, Inc. is a US-based company headquartered in Seattle, Washington, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Atossa Therapeutics, Inc. headquartered?
Atossa Therapeutics, Inc. is headquartered in Seattle, Washington, United States.
Is Atossa Therapeutics, Inc. publicly traded?
Yes — Atossa Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol ATOS on the NASDAQ.
What does Atossa Therapeutics, Inc. do?
Atossa Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
